UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN C000000091
Receipt No. R000000133
Scientific Title The Japan Working Group for the Assessment That the Pioglitazone Protects DM Patients Against Re-Infarction
Date of disclosure of the study information 2005/08/31
Last modified on 2020/03/09 10:08:53

No. Disposal Last modified on Item of update
1 Insert 2005/08/29 21:13:50
2 Update 2009/12/22 22:05:28 Key inclusion criteria
Key inclusion criteria
Target sample size
3 Update 2009/12/22 22:06:03 Recruitment status
Last follow-up date
4 Update 2012/09/20 10:56:28 Last follow-up date
5 Update 2012/09/21 13:54:45 Name of person sending information
Organization
Division name
Address
Post marketing survey by drug manufacture etc., specified by Japanese law.
6 Update 2016/09/06 09:36:56 Email
Last name of contact person
Last name of contact person
Address
Address
Email
Name of primary sponsor
Organization
7 Update 2016/09/06 09:38:43 Randomization unit
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
8 Update 2018/05/22 10:39:19 Interventions/Control_1
Interventions/Control_1



9 Update 2018/05/22 10:41:29 Date of closure to data entry
Date trial data considered complete
Date analysis concluded
10 Update 2018/05/22 10:44:14 Organization
Organization
Division name
Division name
Institute
Institute
Department
11 Update 2018/05/22 11:03:36 Condition
Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
12 Update 2020/03/09 09:35:21 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
13 Update 2020/03/09 09:54:28 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
14 Update 2020/03/09 10:06:19 Organization
Organization
15 Update 2020/03/09 10:08:28 Recruitment status
Date of IRB
16 Update 2020/03/09 10:08:53 Publication of results


Contact us.